<?xml version="1.0" encoding="UTF-8"?>
<p id="para0012">Among substance using populations, global access to treatment for HIV and HCV and harm reduction interventions such as OAT and NSP is woefully low (
 <xref rid="bib0007" ref-type="bibr">Larney etÂ al., 2017</xref>). Inaction will result in substantial economic burden and preventable deaths. Policymakers urgently need information on how to quickly, efficiently, and affordably tackle these complex problems, and the benefits of doing so; modeling can help inform these critical discussions.
</p>
